Skip to main content

Table 1 The basic information of cases and controls

From: Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk

Variable Cases (n = 351) Controls (n = 344) p
Age (Mean ± SD) 55.66 ± 8.46 55.60 ± 8.43 0.923
 ≤ 55 184 178  
 > 55 167 166  
Clinical index    
 CEA 305 105  
 Quantity in serum(ng/ml) 12.55 ± 3.95 2.24 ± 3.14 < 0.001*
 CA125 299 105  
 Quantity in serum (U/ml) 24.23 ± 56.30 13.25 ± 11.52 0.048*
 CA199 285 95  
 Quantity in serum (U/ml) 21.21 ± 58.23 13.91 ± 11.62 0.226
 AFP 303 105  
 Quantity in serum (ng/ml) 9.75 ± 5.28 2.77 ± 0.97 < 0.001*
  1. CEA carcinoembryonic antigen, CA carbohydrate antigen, AFP alpha fetoprotein
  2. *p < 0.05 indicates statistical significance